Verona Pharma, a year after receiving regulatory approval for its landmark chronic obstructive pulmonary disease (COPD) treatment, is being acquired by pharmaceutical giant Merck in a deal worth about ...

Valued at a market cap of $204.3 billion, Merck & Co., Inc. (MRK) is a global healthcare company with a diverse portfolio ...

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Merck's heavy reliance on Keytruda continues to grow, with the drug nearing 50% of total sales and limited growth from other products. Read why MRK is a Buy.

Nike beat expectations in the fourth quarter, but both revenue and profit plunged. The company’s turnaround strategy created some headwinds in the fourth quarter, and the state of the economy ...

The investment community will be closely monitoring the performance of Merck in its forthcoming earnings report. The company is scheduled to release its earnings on July 29, 2025.

Werner Enterprises, Inc. (Nasdaq: WERN), a premier transportation and logistics provider, will release its second quarter earnings on Tuesday, July 29, 2025, ...

Merck Foundation (www.Merck-Foundation.com), the philanthropic arm of Merck KGaA Germany, marks 'World Art Day 2025' through their Pan African 'Art and Fashion with Purpose' Community, established by ...

IRVING, Texas-- (BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2026 financial results after market close on Wednesday, August 6, 2025. The company will host a ...

BLOOMFIELD, Conn., June 25, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will release its second quarter 2025 financial results on Thursday, July 31, 2025, and will host a ...